There are two other delivery options for Bydureon: the Dual Chamber Pen and the BCise autoinjectors.[hmicms_related_articles] Bydureon, a glucagon-like peptide-1 (GLP-1) receptor agonist ...

AstraZeneca announced the availability of Bydureon (exenatide extended-release for injectable suspension) Pen in pharmacies across the country. Bydureon is indicated as an adjunct to diet and ...

The U.S. Food and Drug Administration approved the Bydureon Pen to administer a once weekly medicine for Type 2 diabetes patients. The Bydureon Pen is a pre-filled, single-use pen injector that ...

US regulators have given the thumbs-up to AstraZeneca's pre-filled, single-use pen injector version of its long-acting diabetes drug Bydureon. US regulators have given the thumbs-up to AstraZeneca’s ...

US FDA APPROVES BYDUREON® PEN (EXENATIDE EXTENDED-RELEASE FOR INJECTABLE SUSPENSION) FOR ONCE-WEEKLY TREATMENT OF ADULTS with TYPE 2 DIABETES AstraZeneca today announced that the US Food and Drug ...

The U.S. Food and Drug Administration approved the pre-filled Bydureon Pen to administer a once-weekly dose of medicine, eliminating the need for patients to draw medication from a vial into a ...

AstraZeneca has launched Bydureon as a pre-filled pen. The company will now discontinue the drug in its vial and syringe form to avoid confusion. What is Bydureon? Bydureon is the trade name of ...

AstraZeneca ($AZN) won U.S. approval of its Bydureon pen for once-weekly treatment of Type 2 diabetes. The pen will be the first of its kind to hit the market. The ...

With a view to improve treatment for diabetes patients through innovative technology, product design and development firm Cambridge Consultants in association with AstraZeneca have developed Bydureon ...

AstraZeneca's exenatide extended release for injectable suspension (Bydureon Pen) 2 mg is intended for once-weekly use as an adjunct to diet and exercise in the treatment of adults with type 2 ...

President Donald Trump on Thursday threatened to cut off government contracts with Elon Musk's companies, as the once-close relationship between the world's most powerful man and its richest ...